Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-3
pubmed:dateCreated
2006-11-6
pubmed:abstractText
Endothelial dysfunction is considered as a major risk factor of cardiovascular complications of type I and type II diabetes. Our previous studies have demonstrated that endothelial dysfunction in the small mesenteric arteries from 12-16 week old type II diabetic mice was associated with decreased bio-availability of nitric oxide whereas endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation was preserved. The objective of the present study was to characterize EDHF-mediated relaxations of small mesenteric arteries from db/db mice. A depolarizing concentration of KCl or tetraethylammonium (TEA, 10 mM) significantly inhibited the EDHF-mediated relaxation to acetylcholine and bradykinin in small mesenteric arteries from both db/+ and db/db mice. Charybdotoxin or iberiotoxin alone and a combination of ouabain and barium significantly reduced the maximal relaxation to acetylcholine in small mesenteric arteries from db/db mice and charybdotoxin or iberiotoxin either alone or in combination with apamin reduced the sensitivity to the EDHF-mediated component of the relaxation response to bradykinin. 17-octadecynoic acid, but not catalase, significantly reduced the sensitivity to EDHF-mediated responses to bradykinin in db/db mice; 17-octadecynoic acid had no effect on acetylcholine-mediated relaxations. No differences were, however, detected for mRNA expression levels of calcium-activated potassium channels or connexins 37, 40, 43 and 45. Collectively, these data suggest that bradykinin-induced, EDHF-dependent relaxation in small mesenteric arteries from db/db mice is mediated via cytochrome P450 product that activates the large conductance calcium-activated potassium (BK(Ca) or Slo) channel, whereas the acetylcholine-induced, EDHF-mediated relaxation involves neither cytochrome P450 product nor hydrogen peroxide.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine, http://linkedlifedata.com/resource/pubmed/chemical/Biological Factors, http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Connexins, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Guanylate Cyclase, http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/endothelium-dependent...
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0014-2999
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
551
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
98-107
pubmed:meshHeading
pubmed-meshheading:17027963-Acetylcholine, pubmed-meshheading:17027963-Animals, pubmed-meshheading:17027963-Biological Factors, pubmed-meshheading:17027963-Bradykinin, pubmed-meshheading:17027963-Connexins, pubmed-meshheading:17027963-Cyclooxygenase Inhibitors, pubmed-meshheading:17027963-Cytochrome P-450 Enzyme System, pubmed-meshheading:17027963-Diabetes Mellitus, Type 2, pubmed-meshheading:17027963-Disease Models, Animal, pubmed-meshheading:17027963-Dose-Response Relationship, Drug, pubmed-meshheading:17027963-Enzyme Inhibitors, pubmed-meshheading:17027963-Guanylate Cyclase, pubmed-meshheading:17027963-Hydrogen Peroxide, pubmed-meshheading:17027963-Male, pubmed-meshheading:17027963-Mesenteric Arteries, pubmed-meshheading:17027963-Mice, pubmed-meshheading:17027963-Mice, Inbred C57BL, pubmed-meshheading:17027963-Mice, Mutant Strains, pubmed-meshheading:17027963-Nitric Oxide Synthase, pubmed-meshheading:17027963-Potassium Channel Blockers, pubmed-meshheading:17027963-Potassium Channels, pubmed-meshheading:17027963-RNA, Messenger, pubmed-meshheading:17027963-Vasodilation, pubmed-meshheading:17027963-Vasodilator Agents
pubmed:year
2006
pubmed:articleTitle
Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice.
pubmed:affiliation
The Heart and Stroke/Richard Lewar Center of Excellence in Cardiovascular Research, University of Toronto, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't